Genetic evidence and experimental studies have underlined the importance of interleukin-17 (IL-17)-mediated immunity in the protection against mucosal fungal infections. Specifically, the role of IL-17 in antifungal immunity has been extensively studied in the mouse model of oropharyngeal candidiasis (OPC). CD4 (1) . It was previously demonstrated that this rapid innate type 17 response is essential for fungal clearance (1) . However, the triggers that activate innate immunity in response to C. albicans invasion of the oral mucosa are not fully understood. Transition from the yeast to the hyphal form has been shown to be essential for C. albicans invasion of oral epithelial cells (OECs) and leads to barrier injury (2) . It was recently discovered that candidalysin, a pore-forming pep tide toxin secreted by C. albicans hyphae, is a crucial molecular determinant of epithelial cell damage (3) . In this issue of Science Immunology, Verma et al. (4) have identified candidalysin as the missing link between C. albicans invasion and the expansion of innate TCR + cells in the oral mucosa. Given that C. albicans is a human commensal but is absent in rodents, mice are immunologically naïve to this fungus (1), thus providing a neat experimental system with which to study the rapid activation of innate immunity in response to Candida. Verma et To explain the observed phenotype, the authors next focused on understanding the mechanisms behind the candidalysin-mediated initiation of the innate IL-17 response in the oral mucosa. The induction of rapid innate responses to Candida infection has been previously linked to epithelial damage (8) . Candidalysin is essential to trigger such damage through the activation of a mitogen-activated protein kinase (MAPK) phosphatase MKP1/c-Fosdependent danger response, inducing proinflammatory IL-1 and IL-6 production (3). Pro-IL-1 stored in oral keratinocytes allows for the rapid release of active IL-1 during C. albicans infection (8), a mechanism conserved in response to other pathogens that cause epithelial cell damage (9 −/− mice and reconstituted them with the same or reciprocal bone marrow cells. However, this effort failed to identify a role for IL-1 signaling in hematopoietic or nonhematopoietic cell compartments, suggesting that either the effect of IL-1 on innate TCR + cell expansion was indirect or the involvement of radioresistant cells mediated this effect.
Although assessed only in vitro, IL-17 production appears to further act in a positive feedback loop in synergy with candidalysin to amplify the up-regulation of several cytokines and damage-associated molecular patterns (DAMPs), including IL-1/ by epithelial cells, which are crucial to drive proliferation of IL-17-producing innate oral TCR + cells (Fig. 1) . Overall, the work of Verma et al. suggests that candidalysin acts as a danger signal during the invasion of hyphae through the epithelium and promotes OEC damage that triggers pro tective innate IL-17-mediated antifungal immunity.
Despite establishing a role for candidalysin in alerting the innate T cell response, some important questions remain. What is the mechanism behind candidalysin-triggered initial release of cytokines and DAMPs by the epithelium? Inflammasomes are possible candidates because NLRP3 (7) and NLRC4 (10) responses are important for the control of Candida infection. Are innate TCR + cells able to directly sense epithelial cell damage caused by candidalysin or do they rely on help by other innate cells, such as resident phagocytes or innate lymphoid cells? In the present study, the authors have assessed the effect of candidalysin by using a single strain of C. albicans, SC5314. Yet, a recent study performed with several C. albicans isolates reports that the expression of candidalysin does not always correlate with in vivo pathogenicity (8) . Additional factors are thus likely to further contribute to the capacity of C. albicans to cause epithelial damage. In this regard, further studies on C. albicans-produced toxins might shed light on how this opportunistic fungus modulates innate and adaptive immunity to influence the balance between pathogenicity and commensalism. Because humans are constantly exposed to C. albicans and likely harbor adaptive memory to this fungus, the role of candidalysin during a secondary oral infection remains to be explored. 
